BioSpace News Archive

FDA

Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System

New system adds treatment options for Charcot foot and broadens the Company’s Extremity Fixation portfolio of products

March 22, 2018
·
4 min read
Drug Development

Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood

Final five-year results show ICLUSIG continued to provide clinically meaningful responses, with depth and lasting duration, irrespective of dose reductions, in heavily pre-treated chronic-phase chronic myeloid leukemia patients

March 22, 2018
·
22 min read
Business

Peloton Therapeutics, Inc. Appoints Helen S. Kim, M.B.A. and David Chang, M.D., Ph.D. to Board of Directors

Peloton Therapeutics, Inc., announced today the appointment of two new members to the company’s Board of Directors.

March 22, 2018
·
3 min read
Biotech Beach

Access Scientific, LLC Announces Discovery of the Cause of POWERWAND™ Catheters’ ZERO Bloodstream Infections in over 35,000 Catheter-Days of Published Use

Independent, peer-reviewed published studies and scientific posters on the company’s POWERWAND™ catheters – which now tally over 35,000 catheter-days of use in over 5,000 catheters – all report ZERO associated BSIs.

March 22, 2018
·
2 min read
BioCapital

Aziyo Biologics Expands Bone Repair Franchise with Launch of OsteGro

Innovative processing and delivery characteristics provide significant improvement versus other available products

March 22, 2018
·
2 min read
Business

Second Sight Appoints John T. Blake Chief Financial Officer

Mr. Blake succeeds Thomas Miller, who has served as Chief Financial Officer since 2014.

March 22, 2018
·
7 min read
Business

LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America

Dowell is a sales, marketing and training expert with more than 30 years of professional experience in the ophthalmic industry.

March 22, 2018
·
2 min read
Drug Development

AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer

AbbVie will not seek accelerated approval for Rova-T in third-line relapsed/refractory small cell lung cancer (SCLC)

March 22, 2018
·
6 min read
Business

Neogen reports third quarter results

Current year-to-date revenues were $292,965,000, up 12% compared to $262,747,000 for the same period a year ago.

March 22, 2018
·
12 min read
Business

LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration

LabCorp’s Expertise in Health System Collaborations will Benefit Patients across Eastern Kentucky and Southern West Virginia

March 22, 2018
·
4 min read